Activities > European Action on Global Life Sciences (EAGLES)
European Action on Global Life Sciences (EAGLES)
As a major player in life sciences and holding influential positions in international deliberations, Europe has a responsibility to help the developing world deal with the risks, challenges and opportunities of these technologies, and to facilitate the safe and efficient development and use of life sciences and biotechnology in developing countries.
European Action in Global Life Sciences (EAGLES) intends to address these questions by designing and implementing projects to be carried out mostly by life scientists from developing countries that will stimulate and facilitate activities for the European life sciences to respond to the needs of developing countries.
The members of EAGLES are determined to ensure that the skills and resources of European life sciences are properly used for the benefits of mankind. The members of EAGLES believe:
- That the greatest humanitarian challenges for the life sciences lie in the problems of illness, starvation and environmental degradation which are faced by hundreds of millions of people in our world today, and will be faced by millions more in the coming decades.
- That life scientists everywhere have a responsibility to address these global challenges.
- That European life scientists could and should make a much greater contribution to meet these challenges.
- That European policies should facilitate the life sciences in meeting these challenges.
In addressing these challenges that the people of Europe and their leaders should pay careful attention to the knowledge and advice of distinguished life scientists and humanists from the developing and emerging countries.
EAGLES Homepage
European Federation of Biotechnology
Passeig Lluis Companys, 23
08010 Barcelona
Tel. +93 268 7703
Fax. +93 268 4500
efb@efb-central.org
Activities > European Action on Latin American Functional Foods (EULAFF)
European Action on Latin American Functional Foods (EULAFF)
The EULAFF project focuses on supporting the functional food sectors in Europe and Latin America. It aims at creating an agri-food chain innovation system for identification and development of novel functional foods, in order to build a sustainable bi-regional functional food sector. The specific goals of the EULAFF project will contribute to:
For achieving these goals the project has planned a series of lectures, debates, roundtables and symposia with the participation of authoritative scientists, experts from the industry and several stakeholders from Europe and Latin America. The proposal also includes the development of a virtual community networking system and on-line information resources to support the collaborative effort and to stimulate the dissemination of information pertaining to the use of biological diversity of agricultural crops grown in Latin America with functional food potential.
EULAFF Homepage
Coordinator of the EULAFF Project
Christian Suojanen
Pg. Lluís Companys, 23, 08010 Barcelona, Spain
Phone: + 34 93 268 87 96
Mobile: +34 617 907 347
Fax: +34 93 268 45 00
E-mail: christian@efb-central.org
Executive Director of the EULAFF Project
Dr. Javier Verástegui
Secretary General of BIOEUROLATINA
Calle de Valderribas, 81, 2do. D, 28007 Madrid, Spain
Mobile: +34 630 925 374
E-mail: javier.verastegui@bioeurolatina.com
About the EFB > General Council and General Assembly
General Council and General Assembly
The General Council (GeCo) consists of one representative of each Institutional Member of EFB. The members of the EFB Executive Board , all chairmen of the EFB Sections and Task Groups also belong to the GeCo. The General Council decides on all fundamental matters connected with the work of the Federation. The members of the GeCo meet at the General Assembly (GeAs).
About the EFB > The Executive Board
The Executive Board
The Executive Board consists of all Chairmen of the different EFB Sections and Task Groups, the EFB Secretary General, and the Treasurer.
Three representatives of EFB-Academia (Learned Societies, universities, institutes or other science based public institutions), three representatives of EFB-Industry (companies and National Bioindustry Associations) and three members from the Regional Branch Office managers are elected by the General Assembly and belong to the ExBo. Up to two co-opted ExBo members may be proposed by the President.
The Executive Board has the authority to decide on all activities and operations of EFB except those that explicitly require approval by the General Council. The ExBo elects the EFB President and two to four Vice-Presidents.
ExBo - Members
 Prof. Marc van Montagu EFB President |
 Prof. Brian Clark Vice President, Chairman Task Group on Education & Mobility |
 Prof. Jeff Cole Vice President, Chairman Section on Microbial Physiology |
 Jens Sundbye Treasurer |
||
 Dr. Roland Wohlgemuth Chairman, Section on Applied Biocatalysis |
 Prof. Klaus Ammann Chairman, Section on Biodiversity |
 Prof. Dr. Fabio Fava Chairman, Section on Environmental Biotechnology |
 Dr. Andreani Odysseos Chairman, Section on Medicines Development |
||
 Dr. Guilherme N.M. Ferreira Chairman, Section on Biochemical Engineering Science |
 Dr. Mike Taussig Chairman, Section on Applied Functional Genomics |
 Dr. Wieland Wolf Chairman, Associated Section on Pharma Medical Biotechnology (EAPB) |
 Natalia Borkowska Chairman, Associated Section Young European Biotech Network (YEBN) |
||
 Dr. Bo Heiden Chairman, Task Group on Innovation (TG INN) |
 Dr. Patrick Rudelsheim Chairman, Task Group on Safety in Biotechnology |
 Dr. Diethard Mattanovich Elected Member, Academia |
 Prof. Joost Teixeira de Mattos Elected Member, Academia |
||
 Dr. Carmen Vela Elected Member, Industry |
 Prof. Pierre Monsan Elected Member, Academia |
Dr. Valerie Frankard Chair, Section on Plant Biotechnology |
 Dr. Willi Meier Elected Representative, RBO |
||
 Prof. Francesc Gòdia Elected Representative, RBO |
 Francesco Lescai Elected Member, RBO Bologna. |
 Prof. Wilf Mitchell Co-opted, Academia |
 Prof. Mathias Uhlen Co-opted, Academia |
About the EFB > The EFB Fora
The EFB Fora
The main fora of the EFB are Sections and Task Groups. They accomodate all European scientists interested in biotechnology. Sections are devoted to a particular field of biotechnology (vertical topics) and are open to all personal members. Task Groups cover topics which are of interest to all or most biotechnologists (horizontal topics); you can become a member of a Task Group by invitation only.
Sections may decide to establish Working Groups to address selected issues. Working Groups are operating under the guidance of the Section Board.
Regional Branch Offices > EFB Central Office (ECO)
EFB Central Office (ECO)
The EFB Central Office is located in Barcelona, where the major administrative work within EFB is being taken care of Membership Administration, Organisation of Executive Board meetings and General Assemblies, website management and organisation of the European Congresses on Biotechnology (from 2005 onwards) are some of the main responsibilities of ECO.
Please do not hesitate to contact us in case of general questions regarding EFB:
EFB Central Office (ECO):
Karsten Zimny,
Financial Director & Central Office Manager.
karsten@efb-central.org
Fernando Carreño.
fernando@efb-central.org
Camilo Pizarro.
European Federation of Biotechnology.
Parc Científic Barcelona.Torres R+D+I.
Baldiri Reixac 4-8
08028 Barcelona
Spain
e-mail: efb@efb-central.org
Tel +34 93 402 0599
Fax: +34 93 402 0434
About the EFB > EFB Statutes
EFB Statutes
EFB Statutes 2004 (PDF document)
As the legal seat of the EFB is in Belgium, the official Statutes of the European Federation of Biotechnology as filed with the Ministry of Justice are in French. An English translation of the statutes is available to EFB members upon request to the Central Office, but the French version available for download here is the definitive one.
Sections & Workgroups > Section on Biochemical Engineering Science (ESBES)
Section on Biochemical Engineering Science (ESBES)
Biochemical Engineering Science is an applied science discipline comprising elements from the BioSciences as well as from the defining disciplines of Engineering Science, namely Physics and Mathematics, used to create models for Biological Systems in both small and large scale and to solve these models numerically in order to guide both experimental work and design of processes. Special topics of Biochemical Engineering Science include Analysis of Bioreactors and of Downstream Process equipment in order to optimize the yield of the desired products and of the productivity of the system. Thus, Biochemical Engineering Science can also lead to better control systems through an understanding of the systems dynamics, and through incorporation of molecular tools on a quantitative basis it may lead to the discovery and design of completely new processes or products for the Bio Industry.
The European Federation of Biotechnology established its first Section, the Section on Biochemical Engineering Science (ESBES), in August 1995 by interlinking the Working Parties on Bioreactor Performance, Downstream Processing, and Measurement and Control of the European Federation of Biotechnology. ESBES organises activities that encourage integration and interaction such as:
Bi-annual congresses on Biochemical Engineering
Courses
Exchanges of PhDs, Post-doctoral fellows and lecturers between European laboratories
Workshops on new developments
Presently the Section on Biochemical Engineering Science is an active association of 5 Working Groups:
- Working Group on Downstream Processing
- Working Group on Modelling, Monitoring, Measurement & Control (M3C)
- Working Group on Bioreactor Performance
- Working Group on Biocatalysis
- Working Group on Bioenergy Systems
All European biotechnologists with interest in Biochemical Engineering are invited to become members of ESBES and take part in the activities of the Working Groups.
If you have further questions regarding the work of the Section on Biochemical Engineering Science, please visit the ESBES website or contact:
Dr. Guilherme N.M. Ferreira
ESBES Chairman
University of Algarve
Faculty of Natural Resources
Engineering (FERN)
Campus de Gambelas, 8000-117 Faro, Portugal
Tel: 00351/289/800 900
Fax: 00351/289/81 84 19
E-mail: gferrei@ualg.pt
Sections & Workgroups > Section on Microbial Physiology
Section on Microbial Physiology
Microbial growth and metabolism play key roles in all of the major geochemical cycles of Planet Earth, consuming and replenishing carbon, nitrogen, hydrogen and sulphur in the biosphere. Microbes can be extremely beneficial. They are essential tools in environmental biotechnology, biodegradation, composting, the supply of fresh drinking water, the safe disposal of sewage, and in food, wine and beer production. But they can also cause disease and food deterioration. Microbial physiology is the study of microbial structure and function, in particular, how microbial activity responds to changes in the environment. It is therefore the key to controlling detrimental aspects of microbes, and to exploiting them for the good of the human race.
The EFB Section on Microbial Physiology was founded on 17 August 1997, during an EFB General Assembly. One of its main activities is the organization of high-level scientific symposia. Major features of these activities are:
1. they are interdisciplinary, bringing together molecular microbiologists, geneticists, environmental and industrial biotechnologists and chemical engineers;
2. they are truly international, typically attended by participants from across the world;
3. all sectors are represented: industry, academia, research institutes and government agencies.
Meetings are organized at 2 to 4 year intervals around a series of focused themes that include:
- recombinant protein production;
- analysis of microbial physiology at the single cell level;
- microbial response to environmental stress;
- bacterial electron transfer processes and their genetic regulation; and
- the physiology of yeast and filamentous fungi.
Other activities include participation in short courses; drafting of position papers for the European Commission, and provision of expertise for European governmental agencies.
For information about the last meeting of the Microbial Physiology Section, please give click on: Section Minutes
For further information about the Section on Microbial Physiology, please visit the Section website or contact:
Prof. Dr. Jeff Cole (Chairman)
University of Birmingham
School of Biochemistry
P.O. Box 363
UK, Birmingham B15 2TT
Tel: +44 121 414 5440
Fax: +44 121 414 5925
E-mail: J.A.Cole@BHAM.AC.UK
Sections & Workgroups > Section on Phyto-Pharmaceuticals
Section on Phyto-Pharmaceuticals
Currently there is intense interest worldwide for studying medical treatment derived from traditional medicine sources. The EFB therefore deems it appropriate to start a section on phyto-pharmaceutical science which will network with European scientific experts in the field from various countries which have source material based on natural plant materials from in particular China, Latin America, India and Russia. This section will aim to encourage via its members the establishment of scientific procedures and norms for enabling new biomedical health treatments in prevention of and intervention in the course of human diseases. The section will aim to be a channel for high level research investigation and global co operations to enable new drug discoveries.
In contrast to target oriented Western medicine, traditional use of herbal medicines such as TCM (Traditional Chinese Medicine) uses a holistic, synergetic and personalized approach for diagnosis and treatment. Although products like those from TCM are sold in many countries, there is an insufficient post-market surveillance system, lack of control over quality and safety, no integration of existing knowledge on adverse effects, uncertainty over IPR issues and regulatory requirements, and in general a large need for more advanced knowledge and new approaches to R&D. At the scientific level at the present time there is little understanding about the mechanisms of action of many such therapies, which would be immediately valuable for evidence-based evaluation and improved regulation. Given the complexity of both the human body plus the often complex compositions of the herbal extracts, this requires multidisciplinary research applying advanced tools, in conjunction with holistic approaches, to decipher the scientific fundamentals of the medication.
As the EFB has established Regional Branch Offices (RBO) in Europe and via its task group on international relation, RBOs outside Europe, these can be natural elements for interacting with particular national requirements and national granting bodies including the European Commission and also be available to stimulate networking and high level scientific cooperation between our European members and important interested bodies such as the Chinese Ministeries, responsible for regulating and overseeing the proper use of phyto-pharmaceuticals.
The Board of the new Section will contain representatives of interested parties. To start, the Chairman has been nominated to be Professor Brian Clark and the Executive Director Mr. Jens Sundbye, both at the Danish RBO of the European Federation of Biotechnology.
All Section Members are welcome to become an active participant in this EFB Section.
For further information about the Section activities, please contact:
Prof. Brian F.C. Clark (Chairman)
Institute of Molecular Biology
Gustav Wieds Vej 10
DK-8000 Aarhus C
Denmark
E-mail: bfcc@mb.au.dk
Jens Sundbye (Executive Director)
BioMedico Forum
Forskerparken
Gustav Wieds Vej 10
DK-8000 Aarhus C
Denmark
Tel +45 - 8620 5080
Fax +45 - 8620 1222
E-mail: js@biomedicoforum.dk
Sections & Workgroups > Section on Applied Biocatalysis (ESAB)
Section on Applied Biocatalysis (ESAB)
The EFB section on Applied Biocatalysis (ESAB) is active in the field of Industrial Biotechnology. Industrial Biotechnology is the application of biotechnology for the industrial production and processing of chemical substances, materials and bio-energy. Industrial Biotechnology exploits the synthetic capabilities of the natural world for human needs and typically leads to greener production processes. This technology is mainly based on biocatalysis (the use of enzymes to catalyse chemical reactions) and fermentation technology (directed use of microbial metabolism). Industrial biotechnology (also referred to as white biotechnology) stands apart from the red biotechnology (directed towards health care) and green biotechnology (genetically modified agricultural crops).
Industrial Biotechnology is a technology with a particularly broad application potential in a variety of industries such as the chemical and pharmaceutical industry, the food and feed industry, agro-industry, textile industry, energy sector, etc. These industries increasingly rely on biocatalytic processes to perform a wide range of reactions, improve the cost-effectiveness of existing processes and develop new products and applications. The use of biocatalysis can have significant performance benefits compared to conventional chemical technology, such as a high reaction selectivity, higher reaction rate, increased conversion efficiency, improved product purity, lowered energy consumption and a significant decrease in waste generation. The processes of industrial biotechnology will often rely on renewable resources as a raw material and typically lead to significant ecological and economical benefits.
The former working party on Applied Biocatalysis transformed itself into an EFB Section in September 2000. ESAB is led by a scientific committee consisting of about 40 members from all European countries. Individual scientists with an interest in Industrial Biotechnology are requested to become a member so that they can actively participate in the activities of ESAB and support the development of Industrial Biotechnology in Europe.
he mission of ESAB can be summarized as follows:
- To promote the industrial application of useful biocatalysts
- To develop the science and engineering aspects of industrial biotechnology
- To promote industrial biotechnology in European and national science policies
- To identify key topics which may be rate-limiting for the development of industrial biotechnology and to take steps to stimulate these areas, particularly through the organisation of scientific meetings and conferences
Dr. Roland Wohlgemuth
Sigma-Aldrich, Research Specialties, Buchs, Switzerland
E-mail:roland.wohlgemuth@sial.com
http://www.esabweb.org/
Sections & Workgroups > Associated Section on Pharma Medical Biotechnology (EAPB)
Associated Section on Pharma Medical Biotechnology (EAPB)
The European Association of Pharma Biotechnology (EAPB) is the representative of pharmaceutical biotechnology in Europe. EAPB, as the Associated Section on Pharma Medical Biotechnology of the EFB, is dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to industrial materials, processes, products and their associated issues.
As a non-profit organization EAPB provides a central network linking academia, industry and regulatory bodies. Accordingly its members are professionals from biotechnology and pharmaceutical companies, governmental authorities, academia and scientific organizations.
Events organized by EAPB promote collaborations between science and industry in the sector of pharmaceutical biotechnology. Specifically the technology transfer focused Science to Market Conferences intent to enhance the economical output of scientific research and direct them into marketable technologies and biopharmaceutical products.
For further information regarding this Associated Section, please visit EAPB website or contact:
Dr. Marion Kronabel (Managing Director)
c/o BIO Deutschland
Tegeler Weg 33
10589 Berlin
Telephone +49 30 345059330
Fax +49 30 345059359
E-mail: marion.kronabel@eapb.org
Sections & Workgroups > Section on Biodiversity
Section on Biodiversity
The Section on Biodiversity, an initiative of the European Federation of Biotechnology, was founded on 27 February 2003. The main task of this section is to investigate and debate the impact of Biotechnology on Biodiversity.
Priority topics of the EFB Section on Biodiversity are:
- Benefits and threats from GMO’s
- How can the view on Biodiversity help in research and development?
- Enhance the knowledge about soil microbiology and agricultural biodiversity
- Biodiversity and Population Genetics: A wide field of research
- Active participation in the development and outlining of research programmes on an European level.
For an overview of the topic Biodiversity related to Biotechnology see:
Ammann, K. (20110921)
Review: Can GM crops help to enhance biodiversity? Open Source Version. In ASK-FORCE contribution AF-11, Vol. AF-11, pp. 88. Ammann K., Neuchatel
http://www.ask-force.org/web/AF-11-Biodiversity/AF-11-Biodiversity-Biotechnology-20110921-opensource.pdf
The section leader is maintaining a blog contribution list on biodiversity debate topics:
http://www.efb-central.org/index.php/forums/
Download a summary of the latest updates from September 2011 of all contributions
http://www.ask-force.org/web/ASK-FORCE-Summary/ASK-FORCE-Summary.pdf
The section leader acted also as Guest Editor, together with Prof. em. Ingo Potrykus for the Journal of New Biotechnology: Vatican conference on GM crops and developing countries May 2009, online open source publication 20101130: it can be downloaded at
http://www.sciencedirect.com/science/issue/43660-2010-999729994-2699796
Klaus Ammann
Prof. hon. emeritus, former Director Botanic Garden, University of Bern
Rue de Monruz 20
CH - 2000 NEUCHATEL, Switzerland
Website: www.efb-central.org/Biodiversity/homepage.html
E-mail: klaus.ammann@ips.unibe.ch
Tel.: +41 79 429 70 62, skypeIn +41 33 534 91 52
klaus.ammann@ips.unibe.ch
http://www.efb-central.org/Biodiversity/homepage.html
http://www.efb-central.org/index.php/forums/
http://www.pubresreg.org
Sections & Workgroups > Section on Environmental Biotechnology
Section on Environmental Biotechnology
First Meeting of the Section Experts Group
For more information please click here
Objectives and Activities of the section
The EFB section on Environmental Biotechnology is active in the following fields: a) biomonitoring and bioremediation of xenobiotic compounds occurring in soils, sediments, groundwater and wastewaters; b) the clean up and sanitation of water; c) integrated disposal and valorization (biorefinery concept) of by-products, wastes, effluents and surplus of the agro-food industry with the production of bio-based chemicals, materials and fuels; d) CO2 biocapture, etc.. Environmental biotechnology is mainly based on the tailored exploitation of enzymatic and microbial processes already occurring in the treated environmental matrices or established in bioreactors with dedicated configurations and working operations.
Environmental Biotechnology provides effective and sustainable (from the economical, environmental and social point of view) tools and strategies for a) monitoring and reducing the risk to humans from contaminated sites and from the storage of municipal and industrial (bio)wastes; b) cleaning up and enabling the reuse of industrial wastewater (thus reducing the industrial use of natural water); c) turning biowaste with high environmental impact into biobased, biodegradable and biocompatible chemicals, materials and fuels, with a remarkable reduction of i) human risks associated with the biowaste disposal, ii) use of polluting fossil fuels or food crops for producing chemicals and fuels, and iii) CO2 production and climate change impacts.
Environmental Biotechnology has a broad application potential in a variety of industries such as those involved in the sustainable remediation of sites and wastewaters and the innovative chemical and energetic valorization of biowastes but also, considering the possible end users of the bio-based products resulting from the biowaste biorefineries, in the chemical, textile, and agro-industry as well as in the energy sector.
The EFB Section on Environmental Biotechnology is led by a scientific committee consisting of about 50 members coming from academia, research centers, governmental institutions and industries from European countries. Individual scientists with an interest in Environmental Biotechnology are encouraged to become members so that they can actively participate in the activities of the section and support the development of Environmental Biotechnology in Europe.
The mission of the section can be summarized as follows:
- To develop the science and engineering aspects of modern environmental biotechnology;
- To identify the most prominent European R&D priorities and stakeholder needs in the area of sustainable bioremediation of contaminated sites and wastewaters, biowaste biorefining, water sanitation, CO2 fixation, etc.;
- To promote such priorities and needs towards the European Commission, the OECD, the European Technology Platforms and other European Agencies dealing with environmental protection and restoration;
- To promote international conferences on Environmental Biotechnology in Europe and partner Countries;
- To promote Environmental Biotechnology in the national science policies of European Countries.
Prof. Dr. Fabio Fava (Chairman)
Full Professor of “Industrial & Environmental Biotechnology”
DICAM, Faculty of Engineering, Alma Mater Studiorum-University of Bologna
Via Terracini, 28.
I-40131 Bologna. Italy
Phone:+39 051 2090330
Fax:+39 051 2090348
E-mail: fabio.fava@unibo.it
Web page: http://fabiofava.people.ing.unibo.it
Prof. Dr. Spyros Agathos (Vice Chairman)
Full Professor of Biochemical Engineering
University of Louvain, Louvain-la-Neuve, Belgium
Place Croix du Sud 2/19,
B-1348 Louvain-la-Neuve. Belgium
E-mail:spiros.agathos@uclouvain.be
Web page: http://www.uclouvain.be/en-gebi.html
SECRETARIAT:
CNR - Water Research Institute (http://www.irsa.cnr.it/)
Area della Ricerca Roma 1
Montelibretti, Via Salaria km. 29,300
00015 Monterotondo (RM). Italy
Contact Person: Dr. Valter Tandoi
E-mail: environ.biotech.EFB@irsa.cnr.it
Phone: +39 06 90672782; +39 06 90672769
Fax: +39 06 90672787
Important Links:
Erasmus Mundus - Doctorate on Environmental Technologies for Contaminated Solids, Soils and Sediments. http://www.internationaldoctorate.unicas.it/
Sections & Workgroups > Section on Medicines Development
Section on Medicines Development
With the mapping of the human genome, biotechnology is of increasing importance for development of new and targeted medicines and will impact future medical practice. This calls for an optimising of the current medicines R&D process and a re-thinking of the process. It is for this reason that the Section on Medicines Development was established in 2003. This Section covers all aspects of Medicines Development (which today all will involve biotech in one way or other) as well as all processes within the R&D cycle from idea through research, applied research, preclinical, clinical, regulatory and post-marketing follow-up.
The EFB Section on Medicines Development is a platform for all stakeholders and sciences related to development of medicines. NSMF follows two tracks:
Streamlining:
Activities to optimise and reengineer the current drug research & development processes utilising contemporary scientific knowledge by removing bottlenecks and developing new tools.
Fresh approach:
To re-evaluate the entire drug development process and create a new efficient flow of knowledge generation and management without compromising safety based on recent scientific and technological advances including genome research.
NSMF enjoys strong support from EC DG Research as well as from EUREKA. A steadily increase in members of the section is reflecting that also universities, hospitals, medicines agencies, pharmaceutical companies, and SMEs from most countries in Europe are interested in engaging in this major and strategic initiative. NSMF webpage (www.nsmf.org) provides information about NSMF including an overview of NSMF, reports from workshops, and NSMF relevant events and activities.
At the Board Meeting that took place in the margins of the 14th European Congress of Biotechnology, on September 13, 2009 in Barcelona, the Section on Medicines Development has initiated a joint effort to reform its strategic agenda in the post-IMI era. Key issues on the agenda have included:
-
a. Streamlining activities with patient/consumer/citizen groups (who also work on medicine development and recently achieved some major EU-projects). Specific examples include the EFGCP/EGAN’s working party on “roadmap to treatment”. A structural collaboration is expected to be very productive.
b. Operating a focussed website (perhaps as part of the EFB- website) bringing information on NSMF together.
c. Taking a responsibility for the biotechnology and the SMD- sectors in the planned Virtual Patient Academy.
d. Formulating a manifest for governments/politicians containing opportunities and barriers and also views how to proceed.
e. Identifying the points where where our roads cross with EFGCP, with EuropaBio, with EFPIA, with EuroBio and discuss the options for common action on these cross roads.
NEWS
IMI has launched the third call and are available from the IMI website (www.imi.europa.eu). The official launch of the 3rd Call took place on October 22 2010, Submission start date is December 18, 2010 and the deadline for submission will be till January 18, 2011. Call topics are as follows:
-
1. Improving the early prediction of drug induced liver Injury in man
2. Immunogenicity: assessing the clinical relevance and risk Minimization of antibodies to biopharmaceuticals
3. Immunosafety of vaccines – new biomarkers associated With adverse events (early inflammation, autoimmune Diseases and allergy)
4. Improving the preclinical models and tools for Tuberculosis medicines research
5. Translational endpoints in autism 6. Development of personalized medicine approaches in Diabetes
7. Fostering patient awareness on pharmaceutical Innovation
For information about the activities of this Section please contact:
Dr. Adreani Odysseos (Chairman)
Organisations: EPSO-Iasis, R&D and University of Cyprus
University of Cyprus
Dept. of Chemistry
75, Kallipoleos Street, Nicosia 1678
Tel: +357-22-892218
Fax: +357-22- 894501
E-mail: odysseos@ucy.ac.cy, andreani@epos-iasis.com
Sections & Workgroups > Associated Section YEBN (Young European Biotech Network)
Associated Section YEBN (Young European Biotech Network)
“Biotechnology and young people’s networks are both essential components of Europe’s scientific and technological futures. Accordingly, I strongly endorse the goals and activities of the YEBN.” - Philip Campbell, Ph.D. Editor-in-chief, Nature
Biotechnology is a key factor for sustainable development of our future. The Young European Biotech Network (YEBN) is a non-profit organisation that aims to strengthen the co-operation among European Countries in order to promote a responsible and dynamic community of young scientists and increase the competitiveness of the European Life Science sector worldwide. YEBN was founded in December 2002 in Bertinoro, Italy, by four student organisations active in several European countries. Today, YEBN consists of several hundred members in 15 European countries.
Linking people together has proven to be vital for businesses. A successful scientist has to seek out contacts at conferences as well. Networking is a crucial aspect, not only for career, but for information and also sometimes for fun. YEBN links people within its network and to the outside world, either through its member database or through specific networking events, such as conferences, meetings or workshops. In doing this, YEBN achieves an internal and a vertical integration of its members, for example with academia, other organisations (such as the European Federation of Biotechnology) and companies.
Young Life Scientists are often concerned with their future career. YEBN has built specific career services, such information on job matching databases and its internal networking database to help YEBN members in critical questions, i.e. on getting information of research groups in other countries.
Young people most often have great ideas, as well as the courage and motivation to realize them. Yet, sometimes the space is missing for the creativity to be put into reality.
YEBN helps you to realize your own ideas by helping to find human resource to fill your team, helps you to find financial aid, management skills and most importantly provides its name to leverage your endeavour. Genetic engineering, cloning and other issues have caused widespread anxiety and debates in society. YEBN is dedicated to provide society with unbiased and objective knowledge and information on Life Science, from young involved scientists. YEBN aims for these objectives by representing a young generation of open-minded scientists who can be regarded as trustworthy. Specific projects and Task Groups within YEBN are focused on science and society, public perception and communication of science. A project called BioPop of a new model for science communication and sociology of science under the FP6 program of the European Commission” was accepted and run from 2004.
Everyone is welcome to join and initiate projects in YEBN, membership is for free. We encourage persons with different backgrounds but strong interest in biotechnology to join, in order to create a fruitful interdisciplinary forum.
For further information regarding this Associated Section, please visit the YEBN website or contact the Chairman:
Natalia Borkowska
YEBN Chairman of the Executive Board
E-Mail
http://yebn.eu/
Task Groups > Task Group on International Relations (TGIR)
Task Group on International Relations (TGIR)
The EFB Task Group TGIR aims at the promotion of international (global) interactions and cooperation between governments, industries and academics in the field of biotechnology. Specifically, TGIR formulates proposals to the European Commission and implements EC programmes to establish strategic relations.
One of the main activities of the Task Group is European Focus on Biotechnology in China (EFBIC). EFBIC’s purpose is to establish strategic relations in biotechnology between decision makers in Europe and China and facilitate collaborations in research, training and innovation among European and Chinese scientists.
For further information on the activities of this Task Group please contact:
Prof. Dr. Brian Clark (Chairman)
Department of Molecular and Structural Biology
University of Aarhus
Gustav Wieds Vej 10C
DK-8000 Aarhus C
Tel: +45 - 8942 5055
Fax: +45 - 8619 1959
E-mail: bfcc@mb.au.dk
Task Groups > Task Group on European Action on Global Life Sciences (EAGLES)
Task Group on European Action on Global Life Sciences (EAGLES)
EAGLES was set up through the initiative of members of the European Federation of Biotechnology. It was established as a Task Group, which provides advice and support, as well as an administrative structure and its large network.
EAGLES designs and implements projects to be carried out mostly by life scientists from developing countries that will stimulate and facilitate activities for the European life sciences to respond to the needs of developing countries.
The members of EAGLES believe:
- That the greatest humanitarian challenges for the life sciences lie in the problems of illness, starvation and environmental degradation which are faced by hundreds of millions of people in our world today, and will be faced by millions more in the coming decades.
- That life scientists everywhere have a responsibility to address these global challenges.
- That European life scientists could and should make a much greater contribution to meet these challenges.
- That European policies should facilitate the life sciences in meeting these challenges.
- In addressing these challenges that the people of Europe and their leaders should pay careful attention to the knowledge and advice of distinguished life scientists and humanists from the developing and emerging countries.
For information on the activities of this Task Group please visit the EAGLES website or contact:
European Federation of Biotechnology
Passeig Lluis Companys, 23
08010 Barcelona
Tel. +93 268 7703
Fax. +93 268 4500
efb@efb-central.org
Task Groups > Task Group on Education, Mobility and Professional Qualifications
Task Group on Education, Mobility and Professional Qualifications
The Task Group on Education, Mobility and Professional Qualifications is composed of scientists and managers committed to higher education in the field of biotechnology, in fostering people’s mobility within the European Research Area and beyond, and in ensuring professional qualifications are equally recognised across the European Union.
Some key Universities contribute to the activities, and a close collaboration with European institutions such as the European Commission, EuropaBio and the European University Association provide the network for the task group’s activities.
The Task Group has the following main objectives
1) identify potential collaborations among Universities, in the field of biotech education, and address common issues in educational standards
2) address mobility issues, specific to undergraduate and graduate students in Biotechnology and Life Sciences
3) propose potential joint programs, where its members would like to build up more tight collaborations
4) play a role in the field of professional qualifications, and contribute in shaping a common frame in Europe.
The Task Group has arranged various courses and workshops and also played a key role in developing a variety of European biotechnology education initiatives. This has included the Code of Conduct for Biotechnologists, the European Doctorate in Biotechnology and Professional accreditation for biotechnologists.
If you wish to become a member of the Task Group on Education Mobility and Professional Qualifications, please contact:
Contact Info:
Francesco Lescai (Chairman)
Div. Research Strategy, UCL Genomics
University College London
Gower Street WC1E 6BT London,
United Kingdom
Phone: +44.(0)20.7679.6812
E-mail: francesco.lescai@yebn.org
Regional Branch Offices > EFB RBO Bologna, ITALY
EFB RBO Bologna, ITALY
Region:
The Bologna RBO is located at the Fondazione Marino Golinelli, and serves as EFB Regional Branch Office for Italy.
EFB Activities:
Besides their regional tasks, the EFB RBO Bologna is interested in supporting the EFB Associated Section YEBN (Young European Biotech Network), the Section on Public Engagement and Communication, and participating in the work of the Task Group on Education and Mobility.
Contact:
EFB RBO Bologna
Dr. Marino Golinelli
Fondazione Marino Golinelli
Via Ragazzi del 99 Nº 5
40133 Bologna
Italy
Phone: +39 051 6489 501
Fax: +39 051 389 929
E-mail: info@golinellifondazione.org
http://www.golinellifondazione.org
Regional Branch Offices > EFB RBO Warsaw, POLAND
EFB RBO Warsaw, POLAND
Region:
The Warsaw RBO is located at the Polish Academy of Sciences and serves as EFB Regional Branch Office for Poland.
More Information:
Contact:
EFB RBO Warsaw
Prof. Dr. Tomasz Twardowski
Polish Academy of Sciences
Palac Kultury i Nauki. Plac Defilad 1
00901 Warsaw
Phone: +48 61 8528503
E-mail:Anna.Pokrzywnicka@pan.pl
Regional Branch Offices > EFB RBO Aarhus, DENMARK
EFB RBO Aarhus, DENMARK
Region:
The Aarhus RBO is located at BioMedico Forum and serves as EFB Regional Branch Office for Denmark.
EFB Activities:
Besides their regional tasks, the EFB RBO Aarhus is interested in supporting the work of the EFB Task Group on EAGLES - European Action on Global Life Sciences.
Contact:
EFB RBO Aarhus
Dr. Jens Sundbye
BioMedico Forum
Forskerparken
Gustav Wieds Vej 10
DK-8000 Aarhus C
Phone: +45 8620 1222
E-mail:js@ebiomedicoforum.dk
Regional Branch Offices > EFB RBO Waedenswill, SWITZERLAND
EFB RBO Waedenswill, SWITZERLAND
Region:
The Zwitzerland RBO is located at the Swiss Coordination Committee for Biotechnology SCCB and serves as EFB Regional Branch Office for Switzerland.
Contact:
EFB RBO Switzerland
EFB RBO Switzerland
Dr. Roland Wohlgemuth
Sigma-Aldrich Chemie GmbH
Industriestrasse 25
9470 BUCHS
E-mail: roland.wohlgemuth@sial.com
Phone: +41 81 755 2640
Fax: +41 81 756 5449
Prof. Dr. Bernhard Sonnleitner
Swiss Coordination Committee for Biotechnology SCCB
Campus Reidbach, Einsiedlerstrasse 29
CH-8820 Waedenswill
Phone:+41 58 934 5492
E-mail:bernhard.sonnleitner@zhaw.ch
http://www.sk-biotechnologie.ch/
Regional Branch Offices > EFB RBO Turku, FINLAND
EFB RBO Turku, FINLAND
Region:
The Turku RBO is located at Turku Science Park Ltd and serves as EFB Regional Branch Office for Finland and St. Petersburg.
Contact:
EFB RBO Turku
Mr. Tero Piispanen
Turku Science Park Ltd
Itainen Pitkakatu 4 B
20520 Turku
Phone. +358 2 880 3100
Fax: +358 2 4101610
E-mail: tero.piispanen@turkusciencepark.com
http://www.turkusciencepark.com
Activities > European Focus on Biotechnology in China (EFBIC)
European Focus on Biotechnology in China (EFBIC)
The European Focus on Biotechnology in China (EFBIC) is a collaborative project between the China National Centre for Biotechnology Development and the European Federation of Biotechnology. EFBIC is funded by the European Commission, and supported by the Chinese Ministry of Science & Technology through CNCBD.
The Mission
EFBIC aims to establish strategic relations between high-level decision makers in Europe and China in the field of biotechnology and biological science. With government, science, industry and public interest organisations, EFBIC works to encourage, develop and facilitate collaborations in research, training and innovation between European and Chinese scientists.
Activities
The European Focus on Biotechnology in China is one of the activities of the Task Group on International Relations. The main activities of EFBIC are to:
- Organise China-EU Workshops on key topics of mutual scientific and commercial interests
- Arrange and fund exchanges, visits and fellowships for European and Chinese officials, decision makers, regulators, industrialists and scientists
- Produce briefings on opportunities for joint scientific and commercial development
EFBIC Contact Forum
All Chinese and European scientists, officials, and industrialists interested in joining EFBIC workshops, participating in other EFBIC activities, or contributing to the expansion of the Sino-European network in biotechnology are welcome to register as members of EFBIC Contact Forum with:
Prof. Brian Clark
Chairman of the EFB Task Group on International Relations
Tel: +45 8942 5055
Fax: +45 8619 1959
E-mail: bfcc@mb.au.dk
EFB Home > EFB Regional Branch Office Applications
EFB Regional Branch Office Applications
The general tasks proposed to all approved applicants fall into two categories:
A: Standard Regional Tasks
B: Support and cooperation with selected EFB Sections and Task Groups (optional).
A: Standard Regional Tasks
- Representation to national government and regional authorities
- Coordination of regional and selected projects
- Coordination of or cooperation on selected EC (and other) applications
- Various contacts (ministries, universities, organisations, media)
- Arrange regional meetings, workshops, conferences etc
- Arrange meetings and workshops in the region for EFB Sections and Task Groups
- Regional membership campaigns
- Distribute info about EFB and EFB events in the region
- Ensure EFB presence at relevant events in region
- Establish data base on institutions and contacts in the region
- Disseminate info about EU (and other) funding opportunities in the region
- Facilitate EFB media contacts in the region
- Deliver regional information and data for EFB website, data base, EFB Central Office (ECO) and EFB Executive Board (ExBo).
B: Support and cooperation with selected EFB Sections and Task Groups
Regional Branch Offices which have an interest in doing so are encouraged to work with EFB Sections or Task Groups, and to consider playing an active role in these such as by hosting activities or providing the Secretariat.
Region
Region typically means country or region within a country, although in exceptional circumstances may include neighbouring countries or regions, to be specified in the agreement. Regional Branch Offices (RBOs) are named according to city or country of residence.
Income
Some of the above regional activities may generate income for the RBO subject to agreement with EFB Sections, Task Groups or EFB Central Office (ECO).
Sections and Task Groups
RBOs may support and collaborate with selected Sections or Task Groups according to individual agreements with their chairmen. To ensure proper coordination, new collaborations of this kind need to be approved by the President. The Executive Board may decide to discontinue selected collaborations if in the overall interest of EFB.
Duration
The agreement should be valid for minimum of 2 years and maximum 5 years, automatically renewable upon agreement of both parties.
RBO Fee
The annual EFB membership fee for a Regional Branch Office is €1,500
Important Comment
Please consider the above as guidelines describing EFB’s suggestions for specifications of a collaboration which builds on shared interests and mutual trust. The goal is to develop a mutually beneficial relationship.
Please note that RBOs report to the EFB Executive Board either directly at Executive Board meetings or through the Secretary General and Central Office. RBO delegates will be invited to each Executive Board meeting. All parties are expected to work in a collaborative, flexible and open-minded manner.
Application
To be considered for Regional Branch Office status, a formal application must be submitted to the Secretary General. This will then be discussed at the next Executive Board meeting, to which the candidate will be invited, and approval will be made by simple majority vote of the Executive Board. The application should include
- Formal letter of application
- Description of the applicant & overview of activities
- Description of how the RBO’s activities will support or be of value to the EFB
Guidelines for Regional Branch Offices
Activities
RBOs carry out activities serving interests in the various areas of research and technology and across the sectors of biotechnology covered by the whole EFB (e.g. innovation, education, public perceptions, international relations, biosafety), in close co-operation with Central Office and under the guidance of the Executive Board.
Organisation and operation
RBOs decide their own manner of organisation and operation as long as they adhere to the Mission and Objectives of EFB, are consistent with EFB Statutes and follow the guidance that occasionally may be issued by Executive Board. All activities carried out in the name of the EFB must be approved in advance and must conform to the general principles of EFB.
Status and agreement
Official status as an EFB RBO will be granted and publicized in all appropriate EFB materials, website and at appropriate EFB events. The specific rights and obligations of Branch Offices will be specified in a formal agreement between the Branch Office and EFB.
Funding and financial arrangements
From successful experience, funding for activities at the RBO can be from:
- conferences, symposia, workshops, etc
- contracts for European Commission-funded projects
- industry, as long as EFB interests and independence are not compromised
- national funding bodies, foundations, etc
- collaborations and partnerships with other non-profit and commercial organisations for specific activities as long as EFB interests and independence are not compromised
- journals and other publications
Activities must not deprive the EFB Central Fund, Central Office, Sections or Task Groups of any significant financial income unless agreed upon by the Executive Board. RBO managers are requested to attend the Executive Board meetings of the EFB. Travel expenses for these meetings should be covered by the RBO.
Membership > Join Us
Join Us
Apply for Institutional and/or Personal membership:
- EFB Institutional Membership Form 2012
- Online Application Form for Personal Membership (Free of charge)
Membership Categories & Fees:
| Membership Category | Number of Employees | Annual Fee |
|---|---|---|
| Company | ||
| 1 - 100 employees | €1250 | |
| 101 - 1000 employees | €2500 | |
| 1001 - 5000 employees | €3750 | |
| > 5000 employees | €5000 | |
| University | ||
| 1 - 1000 biotechnologists | €625 | |
| 1001 - 10000 biotechnologists | €1250 | |
| Institute | ||
| 1 - 1000 biotechnologists | €625 | |
| > 1000 biotechnologists | €1250 | |
| Learned Society | ||
| 1 - 1000 biotechnologists | €625 | |
| > 1000 biotechnologists | €1250 | |
| National Biotechnology Association (NBA) | ||
| - | €1250 | |
| Personal | ||
| - | Free of charge | |
Regional Branch Offices > EFB RBO Frankfurt, GERMANY
EFB RBO Frankfurt, GERMANY
Region:
The Frankfurt RBO is located at Dechema and serves as EFB Regional Branch Office for Germany.
Contact:
EFB RBO Frankfurt
Dr. Willi Meier
DECHEMA e.V.
Theodor-Heuss-Allee 25
D-60486 Frankfurt, Germany
Phone +49 69 7564 143
Fax +49 69 7564 418
E-mail: meier@dechema.de
http://www.dechema.de
Regional Branch Offices > EFB RBO Paris, FRANCE
EFB RBO Paris, FRANCE
Region:
The Paris RBO is located at the Comité Adebiotech and serves as EFB Regional Branch Office for France.
More Information:
Contact:
EFB RBO Paris
Prof. Pierre Monsan
Comité Adebiotech
135 Avenue de Rangueil
F-310077 Toulouse
Phone +33 05 61 55 94 15
Fax +33 5 61 55 94 00
E-mail:Pierre.Monsan@insa-toulouse.fr
http://www.adebiotech.org/
Regional Branch Offices > EFB RBO Madrid, SPAIN
EFB RBO Madrid, SPAIN
Region:
The Madrid RBO is located at the Spanish Society of Biotechnology (SEBiot) and serves as EFB Regional Branch Office for Spain.
Contact:
EFB RBO Madrid
Dra. Carmen Vela
Sociedad Española de Biotecnologia (SEBIOT)
Vitubrio 8
E-28006 Madrid
Phone: +34 91 561 3464
E-mail: cvela@ingenasa.es
http://www.sebiot.org
Regional Branch Offices > EFB RBO Ljubljana, SLOVENIA
EFB RBO Ljubljana, SLOVENIA
Region:
The Ljubljana RBO is located at the National Institute of Chemistry and serves as EFB Regional Branch Office for Slovenia.
Contact:
EFB RBO Ljubljana
Dr. Vladka Gaberc Porekar
National Institute of Chemistry
Hajdrihova 19
SI-1000 Ljubljana
Phone: +386 1 4760 241
E-mail:vladka.gaberc.porekar@ki.si
http://www.ki.si/
Members Directory > Universities
Universities
Members Directory > Learned Societies
Learned Societies
Members Directory > Private Companies
Private Companies
EFB Home > News Room/Press Releases
News Room/Press Releases
 | ||||||
|---|---|---|---|---|---|---|
|
January 2012 - European Federation of
Biotechnology |
 |
|---|
|
Applied Synthetic Biology in Europe - Only 19 days left to register! |
|---|
 Registration is now open: registration closes on 30th January; and Abstracts must be submitted by 20th January. Applied Synthetic Biology in Europe combines science and engineering to design and construct artificial biological functions and systems not found in nature to solve specific scientific problems. It is increasingly relevant to the European Biotechnology industries: current challenges range from the design of new pharmaceuticals to environmental biotechnology, biofuels, novel biocatalysts and sustainable sources of food. For more information please click on the following link: Synthetic Biology. We would like to thank the following organizations for their support:
 |
|
15th European Congress on Biotechnology - Registration now open! |
|---|
Registration is now open. For
more information please click
here. |
|
Environmental Microbiology & Biotechnology Conference 2012 |
|---|
EMB2012 aims to explore the major advances, frontiers and applications of Environmental Microbiology and Biotechnology in the modern area of the knowledge-based bio and green economy.  In particular, the conference will focus on the
sustainable decontamination of polluted habitats, water resource
purification and reuse, biofixation of climate change-inducing gases and
the production of biobased chemicals, materials and fuels from biowaste
or/and via the exploitation and management of novel microbes from non
conventional or impacted habitats. For more information, please click here.
|
|
HealthCompetence.eu |
|---|
 |
 |
|---|
|
Date |
EFB Events |
Venue |
|
6 -8 February |
Barcelona | |
|
10 - 12 |
Bologna | |
|
10 - 13 April |
Bologna | |
|
2 - 4 May |
Lisbon | |
|
10 - 13 May |
Belgirate | |
|
5 - 8 June |
Santarem | |
|
25 - 28 June |
Prague | |
|
29 - 31 August |
Greifswald | |
|
19 - 21 September |
Greifswald | |
|
23 - 26 September |
Istanbul | |
|
2013 |
Laupheim | |
|
2013 |
Information | |
|
21 - 25 April |
Prague | |
|
2013 |
Manchester | |
|
Date |
Other Events |
Venue |
|
9 - 11 February |
Hyderabad | |
|
26 - 29 February |
Graz, StyriaAustria | |
|
February 29 - March 3 2012 |
Alpbach/Tyrol | |
|
19 - 22 March |
Istanbul | |
|
4 - 6 June |
Toulouse |
|
European Federation of Biotechnology Partner | |
|
| |
|
About This E-Mail |
EFB Home > News Room/Executive Biographies
News Room/Executive Biographies
| News Releases | Press Kit | Biographies | In the News | Image Gallery | Media Contacts |
|---|
Executive Biographies |
||
|---|---|---|
The European Federation of Biotechnology is governed by an Executive Board comprised of representatives from Industry and Academia. Reporters may obtain biographies of other executives by contacting the EFB Central Office.
|
||
 |
Em. Prof. Marc Van Montagu President, European Federation of Biotechnology Together with his colleague Prof. Jeff Schell, Em. Prof. Marc Van Montagu discovered the gene transfer mechanism between Agrobacterium and plants, which resulted in the development of methods to alter Agrobacterium into an efficient delivery system for gene engineering in plants. He has received numerous outstanding awards for his pioneering work. Read more. |
|
 |
Prof. Charlie Bryce Vice President, European Federation of Biotechnology Professor Bryce is Head of School of Life Sciences at Napier University, Chairman of the EFB Task Group on Education & Mobility, Secretary General of the European Association for Higher Education in Biotechnology and Visiting Professor at Zhengzhou University in China. Read more. |
|
 |
Prof. Brian Clark Vice President, European Federation of Biotechnology Brian Clark is Prof. of Biostructural Chemistry at the University of Åarhus in Denmark. His expertise involves decoding of the initiation of protein synthesis and the structural elucidation of transfer RNA. His current research interests centre on relation structure and function and identifying functional protein in functional genomics. Read more. |
|
 |
Prof. Jeff Cole Vice President, European Federation of Biotechnology Jeff Cole is Professor of Microbial Physiology and Biochemistry at the University of Birmingham and Deputy Editor in Chief of FEMS Microbiology Letters. His major scientific experiences include regulation of anaerobic bacterial metabolism, nitrate and nitrite reduction to ammonia, bacterial electron transfer pathways and pathogenicity of bacteria. Read more. |
|
EFB Home > News Room/In the News
News Room/In the News
|
The Programme and book of Abstracts for the meeting will be finalized on Friday and will be sent to press next Monday. Please submit your Abstract immediately if you wish it to be included in the meeting booklet. Final deadline: 17.00 on Thursday 26th January
Late registrations will be accepted without penalty until Friday 3rd February. However, it will not be possible to include in the printed programme for the meeting any late abstracts submitted after Thursday 26th January.
Several sessions for the meeting have been over-subscribed, with more requests for oral presentations than can be included in an already packed programme. However, there remains an opportunity for one group working on the synthetic biology of biofuel production to present their work orally on Wednesday morning, 8th February (15-minute presentation with 5 minutes for questions and discussion). If you wish to offer a presentation for this slot, please contact Tim Overton immediately:
There are still four scholarships of €200 available to decrease the registration fee for graduate students or young scientists to attend the meeting. These are available for students or young scientists working in the same institution as anyone who has paid the normal registration fee (€395 for academia; €495 for industrialists whose company is not an EFB Institutional Member).
For details of benefits of Institutional Membership and how to join, go to: http://www.efb-central.org/images/uploads/EFB Institutional Membership Application Form 2012.pdf
We gratefully acknowledge the following for their financial support:
|
